Ostarine will be the closest SARM to staying authorised in medicine and is at present in section II medical trials. Like SARMs on the whole, MK-2866 targets androgen receptors over a selective basis and avoids making the types of unsafe side effects affiliated with substances like testosterone, human growth hormone, https://thomase432uka0.ja-blog.com/profile